Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
11.85B
Market cap11.85B
Price-Earnings ratio
21.95
Price-Earnings ratio21.95
Dividend yield
Dividend yield
Average volume
1.04M
Average volume1.04M
High today
$88.62
High today$88.62
Low today
$85.52
Low today$85.52
Open price
$86.62
Open price$86.62
Volume
1.34M
Volume1.34M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $87.74, with a market capitalization of 11.85B. The stock trades at a price-to-earnings (P/E) ratio of 21.95.

On 2026-04-01, Globus Medical(GMED) stock traded between a low of $85.52 and a high of $88.62. Shares are currently priced at $87.74, which is +2.6% above the low and -1.0% below the high.

Globus Medical(GMED) shares are trading with a volume of 1.34M, against a daily average of 1.04M.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

GMED News

Simply Wall St 3d
Will Board Exit and New Coverage Reframe Globus Medical’s Governance and Growth Narrative?

Globus Medical, Inc. recently announced that Director John A. DeFord, PhD, resigned from its Board of Directors with immediate effect and will not stand for re-...

Will Board Exit and New Coverage Reframe Globus Medical’s Governance and Growth Narrative?
Simply Wall St 6d
Globus Medical Director Exit Puts Governance And M&A Oversight In Focus

Globus Medical (NYSE:GMED) has announced that board director John A. DeFord is stepping down from its Board of Directors with immediate effect. DeFord served o...

Globus Medical Director Exit Puts Governance And M&A Oversight In Focus
Nasdaq 7d
Should You Retain Henry Schein Stock in Your Portfolio for Now?

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust par...

Should You Retain Henry Schein Stock in Your Portfolio for Now?

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.